Literature DB >> 16175413

Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting.

Bob Djavan1, Yan Kit Fong, Aziz Chaudry, Andreas Reissigl, Theodore Anagnostou, Fariborz Bagheri, Matthias Waldert, Harun Fajkovic, Sibylle Marihart, Mike Harik, Simone Spaller, Mesut Remzi.   

Abstract

To determine the effect of phytotherapy (Serona repens) on the clinical progression in men with mild symptoms of bladder outlet obstruction (BOO). A total of 189 patients with mild symptoms of BOO, recruited from four different European clinics, were included in the analysis. Age, prostate specific antigen (PSA), international prostate symptom score (IPSS), quality of life (QOL), maximum urinary flow rate (Qmax) and total prostate and transitional zone volume were recorded. Clinical progression was defined as change from the mild-IPSS group into the moderate or severe group or the occurrence of urinary retention and need of surgery. Cumulative progression rate was 1, 7, 9 and 16% at 6, 12, 18 and 24 month, respectively, for the active group (Serona repens) as compared to 6, 13, 15 and 24% for the watchful waiting group. (P=0.03) significant improvements in the Qmax, IPSS and QOL were seen in the group receiving Serona repens. Serona repens significantly reduced the clinical progression rates in men with mild symptoms of BOO. It also led to improvements in urinary symptoms, QOL scores and urinary flow rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175413     DOI: 10.1007/s00345-005-0005-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  11 in total

1.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

2.  Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.

Authors:  P Boyle; C Robertson; F Lowe; C Roehrborn
Journal:  Urology       Date:  2000-04       Impact factor: 2.649

3.  Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.

Authors:  G S Gerber; D Kuznetsov; B C Johnson; J D Burstein
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

4.  Growing use of medicinal botanicals forces assessment by drug regulators.

Authors:  C Marwick
Journal:  JAMA       Date:  1995-02-22       Impact factor: 56.272

5.  Health-related quality of life associated with lower urinary tract symptoms in four countries.

Authors:  C J Girman; S J Jacobsen; T Tsukamoto; F Richard; W M Garraway; P P Sagnier; H A Guess; T Rhodes; P Boyle; M M Lieber
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

6.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

Authors:  Garry Welch; Katie Weinger; Michael J Barry
Journal:  Urology       Date:  2002-02       Impact factor: 2.649

7.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

Authors:  John D McConnell; Claus G Roehrborn; Oliver M Bautista; Gerald L Andriole; Christopher M Dixon; John W Kusek; Herbert Lepor; Kevin T McVary; Leroy M Nyberg; Harry S Clarke; E David Crawford; Ananias Diokno; John P Foley; Harris E Foster; Stephen C Jacobs; Steven A Kaplan; Karl J Kreder; Michael M Lieber; M Scott Lucia; Gary J Miller; Mani Menon; Douglas F Milam; Joe W Ramsdell; Noah S Schenkman; Kevin M Slawin; Joseph A Smith
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

8.  Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia.

Authors:  S A Kaplan; E T Goluboff; C A Olsson; P A Deverka; J J Chmiel
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

9.  Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.

Authors:  M Grasso; A Montesano; A Buonaguidi; M Castelli; C Lania; P Rigatti; F Rocco; B M Cesana; C Borghi
Journal:  Arch Esp Urol       Date:  1995 Jan-Feb       Impact factor: 0.436

10.  The attitudes, behaviors and beliefs of patients of conventional vs. complementary (alternative) medicine.

Authors:  A Furnham; J Forey
Journal:  J Clin Psychol       Date:  1994-05
View more
  5 in total

1.  Best of the 2003 AUA Annual Meeting: Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003, Chicago, IL.

Authors: 
Journal:  Rev Urol       Date:  2003

2.  Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy.

Authors:  Yan Kit Fong; Sibylle Marihart; Mike Harik; Bob Djavan
Journal:  Rev Urol       Date:  2004

3.  Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.

Authors:  Antonio Alcaraz; Mauro Gacci; Vincenzo Ficarra; José Medina-Polo; Andrea Salonia; Jesús M Fernández-Gómez; Alexandru Ciudin; David Castro-Díaz; Alfredo Rodríguez-Antolín; Joaquín Carballido-Rodríguez; José M Cózar-Olmo; Santiago Búcar-Terrades; Noemí Pérez-León; Francisco J Brenes-Bermúdez; José M Molero-García; Antonio Fernández-Pro Ledesma; Michael Herdman; José Manasanch; Javier C Angulo; On Behalf Of The Qualiprost Study Group
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

4.  The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.

Authors:  Gerald L Andriole; Christie McCullum-Hill; Gurdarshan S Sandhu; E David Crawford; Michael J Barry; Alan Cantor
Journal:  J Urol       Date:  2012-12-14       Impact factor: 7.450

5.  Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.

Authors:  Letteria Minutoli; Domenica Altavilla; Herbert Marini; Mariagrazia Rinaldi; Natasha Irrera; Gabriele Pizzino; Alessandra Bitto; Salvatore Arena; Sebastiano Cimino; Francesco Squadrito; Giorgio Ivan Russo; Giuseppe Morgia
Journal:  J Biomed Sci       Date:  2014-03-10       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.